Overview

Reduction of Demoralization After Treatment of TD With Valbenazine

Status:
Not yet recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this research project is to determine the feasibility of a larger study aimed at demonstrating that treatment of tardive dyskinesia with Valbenazine is associated with reduction of demoralization
Phase:
Early Phase 1
Details
Lead Sponsor:
Yale University
Collaborator:
Neurocrine Biosciences